Route 92 Medical’s FreeClimb 88 Catheter System Launched

July 22, 2024—Route 92 Medical, Inc. announced commercial launch of the FDA 510(k)-cleared FreeClimb 88 catheter system for navigation through tortuous anatomy in the neurovasculature.

According to the company, the system is composed of the FreeClimb 88 catheter and the Tenzing 8 delivery catheter, which are designed to work with the Base Camp sheath. It is available in 125 and 132 cm lengths to provide clinicians with the flexibility needed to reach targeted locations.

Route 92 Medical stated that the Tenzing 8 delivery catheter’s soft, tapered tip reduces ledge effect and allows the FreeClimb 88 catheter to consistently navigate past the ophthalmic artery and predictably reach the M1 segment of the middle cerebral artery. The tip provides atraumatic tracking in the neurovasculature and was designed to reach the targeted locations without the use of a microcatheter.

In the press release, the device was discussed by Ajit Puri, MD, who is Professor and Director of Neurointervention and Integrated Cerebrovascular Program at University of Massachusetts Medical Center in Worcester, Massachusetts, and Portsmouth Regional Hospital in Portsmouth, New Hampshire.

“Having a broader set of tools gives clinicians greater flexibility when treating difficult cases,” commented Dr. Puri. “The 0.088-inch catheter systems will make procedures easier by minimizing set-up complexity, providing vessel size matching leading to distal flow control during the delivery of therapeutic devices, and leveraging the strengths of the Tenzing product design to improve navigation.”